Strengthening trust through authentic medicines

The trust between a patient and the healthcare system is fundamentally based on the safety, efficacy and genuineness of the prescribed medicine. But, when that trust is broken, especially for life-saving treatments like oncology drugs, the consequences can be life-threatening. Behind every counterfeit medicine lies a human story of families placing their faith in a treatment protocol, only to be let down by systemic failure. The margin for error is razor thin for cancer patients as the treatment regimen requires highest precision in dosage, formulation, and purity. Even a minor deviation in drug efficacy or safety can derail therapeutic outcomes, leading to progression of disease, and significantly increasing the cancer burden. 

This incident underscores a pressing need to tighten regulatory frameworks, ensure robust supply chain verification, and create awareness among patients and healthcare providers alike. Oncologic treatments rely on precise dosing schedules, careful monitoring, and, often, specific instructions on appropriate storage and handling, A single compromised dose can disrupt that balance by containing too little active ingredient or some toxic additive, thereby leading to the collapse of the entire treatment plan. 

Progress and enforcement: Strong steps in the right direction

Recognising the grave risk posed by counterfeit medicines, the government has initiated a series of nationwide actions aimed at curbing this menace. Raids, prosecutions, and rigorous drug sample testing are underway across states. These efforts are not only targeting illegal manufacturers and distributors but also disrupting the networks that support such activities. Significant investments are also being made to bolster infrastructure. Under various centrally sponsored schemes, ₹95 lakh has been allocated towards expanding drug testing laboratories and upgrading technological capabilities. This includes advanced instrumentation, trained manpower, and AI-driven analysis that can detect anomalies faster and more accurately than ever before.

In tandem, government-backed solutions such as barcoding and serialisation have also been implemented to enable traceability throughout the pharmaceutical supply chain. These “track and trace” systems offer consumers the ability to verify the authenticity of medicines using QR codes and mobile apps, adding an extra layer of security from production to point-of-sale.

Reinforcing the last mile: Key solutions for oncology care

Despite many commendable measures in place, cancer patients remain among the most vulnerable, and more targeted efforts are needed to protect them from the dangers of counterfeit or unsafe medications. Every stakeholder, be it policymakers, pharmaceutical companies, hospitals, or civil society, has a role to play, but patients and their families also hold the power to ensure their treatment is safe and authentic.

The first and most crucial step is to always buy medicines from certified and verified pharmacies. If you notice sudden price discrepancies or receive drugs in unlabelled or suspicious packaging, consider it a serious red flag and report it immediately. While barcoding is currently mandated for only the top 300 drug brands, it is vital that this practice extends to all cancer medicines. High-risk therapies should carry secure, cryptographic signatures that cannot be cloned, ensuring the medicine you receive is exactly what your doctor prescribed.

Patients should also know that authentic oncology medicines can and should be verified in real time. Only those pharmacies connected to the Central Drugs Standard Control Organisation (CDSCO) database can guarantee that each vial is traceable to its origin. Hospitals and cancer care centres can support you by including QR code verification in pre-treatment counselling, and caregivers can use official apps to scan and confirm the authenticity of every dose before administration.

Most importantly, do not be tempted by suspiciously low-priced deals, especially online. It is natural to look for cost savings, but counterfeit medicines can not only derail your treatment, they can endanger your life. Always discuss the source of your medication with your doctor, ideally at the very beginning of your treatment or when your therapy changes.

By staying alert, asking the right questions, and verifying your medicines, you can protect yourself and your loved ones because in cancer care, authenticity is not just about quality, it is about survival.

Way Forward: Towards a national movement for safe medicines

Ultimately, safeguarding patient lives is a shared responsibility. Government regulation, pharmaceutical innovation, frontline clinical vigilance, and public awareness must work hand in hand. The oncology community, with its structured treatment protocols and regular patient interactions, is uniquely positioned to lead this charge. The goal is not only to eliminate counterfeit medicines but to restore and reinforce public trust in India’s healthcare system. As we move forward, every genuine dose administered is a life potentially saved, and every counterfeit one prevented is a life protected.

END OF ARTICLE